ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,033.13
0.29%
US Tech 100
16,944.60
0.50%
다우존스 지수
38,025.74
0.32%
Bitcoin
59,077.92
1.45%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Protagonist Therapeutics Inc (PTGX)

  7. Protagonist Therapeutics Inc (PTGX) 뉴스

PTGX Protagonist Therapeutics Inc

25.49
-0.07 (-0.27%)
최종 업데이트: 01:17:26
15분 지연
기업명 주식 심볼 시장 주식 타입
Protagonist Therapeutics Inc PTGX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.07 -0.27% 25.49 01:17:26
개장가 저가 고가 종가 전일 종가
25.74 25.28 26.21 25.56
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
16/04/202422:00GLOBETurnstone Biologics Appoints William Waddill to its Board of..
02/03/202410:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202410:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202410:27EDGAR2Form 144 - Report of proposed sale of securities
02/03/202406:32EDGAR2Form 144 - Report of proposed sale of securities
01/03/202407:48EDGAR2Form 144 - Report of proposed sale of securities
29/02/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202406:12EDGAR2Form 8-K - Current report
14/02/202421:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202421:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/02/202406:05EDGAR2Form 8-K - Current report
19/01/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/01/202422:01EDGAR2Form 8-K - Current report
12/01/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202407:25EDGAR2Form 144 - Report of proposed sale of securities
08/01/202422:00EDGAR2Form 8-K - Current report
05/01/202410:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202410:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202410:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202410:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202410:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202410:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202410:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202306:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/11/202306:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202305:40EDGAR2Form 8-K - Current report
31/10/202305:30EDGAR2Form 8-K - Current report
24/10/202305:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/08/202305:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/08/202305:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/08/202305:13EDGAR2Form 8-K - Current report
05/07/202321:00EDGAR2Form 8-K - Current report
04/07/202305:06EDGAR2Form 8-K - Current report
12/05/202320:00PRNUSProtagonist Reports Positive Results from Phase 1 and..
12/05/202305:05PRNUSProtagonist Therapeutics to Participate in the JMP..
11/05/202323:17PRNUSProtagonist Therapeutics Announces Presentations at the 2023..
05/05/202305:05PRNUSProtagonist Reports First Quarter 2023 Financial Results and..

최근 히스토리

NASDAQ
PTGX
Protagonist Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유